Chimerism Monitoring Panel (Post Transplant)
The Chimerism Monitoring Panel is a specialized molecular test performed after a bone marrow or stem cell transplant to evaluate how successfully the donor cells have engrafted in the recipient’s body.
This test helps doctors determine:
- Percentage of donor cells vs recipient cells
- Success of the transplant
- Early signs of graft rejection
- Risk of disease relapse
- Need for further treatment or immunotherapy adjustments
Why is this test important?
After transplantation, continuous monitoring is essential to ensure healthy donor cells are growing properly. Chimerism analysis provides valuable insight into:
- Engraftment status
- Treatment response
- Long-term transplant success
- Early clinical intervention if abnormalities appear
Sample Required
- Peripheral Blood / Bone Marrow sample
Technology Used
- STR / PCR-based Molecular Analysis
Recommended For
- Post Bone Marrow Transplant Patients
- Stem Cell Transplant Follow-up
- Hematological Malignancy Monitoring
Benefits
✔ Accurate donor-recipient cell analysis
✔ Early detection of graft failure
✔ Supports personalized post-transplant care
✔ Reliable molecular monitoring
Timely monitoring can improve transplant outcomes and patient management.
